Specifically, we engineer TGF-β-gated IL-2 (TGF-β→IL-2) and IL-10-gated IL-2 (IL-10→IL-2) cytokine adaptors that reverse T cell inhibition and have potential applications in cancer therapy. The gene discussed is IL10; the disease is cancer.